Ontunisertib not checked

Agomab Spain S.L. · ORG-129 · AGMB-129

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
2 active
7 in total · 5 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Fibrostenotic Crohn's Disease (2 trials)
Main trialPhase 2
“Many patients with Crohn's disease (CD) develop fibrotic narrowing (strictures) in their bowel, causing obstructive symptoms such as abdominal pain, cramping, or vomiting after meals. Because of these symptoms, patients often require bowel resection surgery. The objective of this clinical trial is to evaluate the efficacy, safety, and dose-response relationship of ontunisertib in participants with CD and symptomatic strictures, and contribute to the validation of novel endpoints to assess potential treatment benefit in patients with fibrostenosing Crohn's disease (FSCD). The participants…”In the company’s words, NCT07683325 on ClinicalTrials.gov
Other names
ORG-129 · AGMB-129

Other drugs for Fibrostenotic Crohn's Disease

All 103 drugs for Fibrostenotic Crohn's Disease

Coming up2

Changes1

Last 90 days

Trials7

TrialPhaseCompletesWhat it tests
Phase 2Recruiting 31 Dec 2028 NOV-ERA - A Clinical Trial to Assess the Efficacy and Safety of Ontunisertib Compared to Placebo in Patients With Fibrostenosing Crohn's Disease
Phase 1Recruiting 31 Jan 2027 Human Mass Balance Study of [14C] Ontunisertib in Healthy Volunteers
Phase 2Completed 20 Jun 2026 STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease
Phase 1Completed 12 Dec 2022 First in Human Study of ORG-129 in Healthy Volunteers
Phase 1Completed 6 Sep 2023 Drug-Drug Interaction Study With AGMB-129 and Midazolam in Healthy Participants
Phase 1Completed 8 May 2024 Relative Bioavailability and Effect of Food Study With AGMB-129 in Healthy Participants
Phase 1Completed 15 Sep 2025 A Multiple Ascending Dose Study With AGMB-129 in Healthy Participants
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Ontunisertib

Following is part of Solo: you see every change to Ontunisertib the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in